Literature DB >> 20063099

[Inflammatory myofibroblastic tumor].

I Leuschner1.   

Abstract

Inflammatory myofibroblastic tumor (IMT) is a soft tissue lesion which can be found in almost all parts of the human body, but shows the highest incidence in the abdomen. It is a spindle cell lesion with prominent inflammatory infiltrate which consists predominantly of plasma cells. Using immunohistochemistry a myofibroblastic differentiation can be demonstrated. ALK is expressed in approximately 50% of tumors. The tumors are associated with a benign behavior but recurrences occur in about one third of abdominal cases. Malignant cases are rare.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20063099     DOI: 10.1007/s00292-009-1262-9

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  6 in total

Review 1.  Inflammatory myofibroblastic tumor, inflammatory fibrosarcoma, and related lesions: an historical review with differential diagnostic considerations.

Authors:  C M Coffin; L P Dehner; J M Meis-Kindblom
Journal:  Semin Diagn Pathol       Date:  1998-05       Impact factor: 3.464

2.  Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma.

Authors:  Elizabeth A Montgomery; Dawn D Shuster; Ashlie L Burkart; Jose M Esteban; Anita Sgrignoli; Lori Elwood; David J Vaughn; Constance A Griffin; Jonathan I Epstein
Journal:  Am J Surg Pathol       Date:  2006-12       Impact factor: 6.394

Review 3.  Myofibroblastic malignancies.

Authors:  Cyril Fisher
Journal:  Adv Anat Pathol       Date:  2004-07       Impact factor: 3.875

4.  Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor). A clinicopathologic and immunohistochemical study of 84 cases.

Authors:  C M Coffin; J Watterson; J R Priest; L P Dehner
Journal:  Am J Surg Pathol       Date:  1995-08       Impact factor: 6.394

5.  Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases.

Authors:  Cheryl M Coffin; Jason L Hornick; Christopher D M Fletcher
Journal:  Am J Surg Pathol       Date:  2007-04       Impact factor: 6.394

6.  Inflammatory fibrosarcoma of the mesentery and retroperitoneum. A tumor closely simulating inflammatory pseudotumor.

Authors:  J M Meis; F M Enzinger
Journal:  Am J Surg Pathol       Date:  1991-12       Impact factor: 6.394

  6 in total
  5 in total

1.  [Thoracic inflammatory pseudotumors : A rare differential diagnosis].

Authors:  S Sponholz; M Schirren; N Baldes; L Schreiner; A Fisseler-Eckhoff; J Schirren
Journal:  Chirurg       Date:  2018-04       Impact factor: 0.955

2.  [Inflammatory myofibroblastic tumor of the greater omentum in a 1.5-year-old boy].

Authors:  K Backhaus; S Grasshoff-Derr; K Ernestus; T Meyer
Journal:  Chirurg       Date:  2012-09       Impact factor: 0.955

3.  Inflammatory myofibroblastic tumor of the liver mimicking an infiltrative malignancy in computed tomography and magnetic resonance imaging with Gd-EOB.

Authors:  Tahir Durmus; Carsten Kamphues; Hendrik Blaeker; Christian Grieser; Timm Denecke
Journal:  Acta Radiol Short Rep       Date:  2014-08-22

4.  A case of ALK-positive histiocytosis with multiple lesions in the unilateral breast: A case report.

Authors:  Arisa Kurita; Masayuki Yoshida; Takeshi Murata; Akihiko Yoshida; Nachiko Uchiyama; Shin Takayama
Journal:  Int J Surg Case Rep       Date:  2022-07-21

5.  Inflammatory myofibroblastic tumor of the small bowel: a case report.

Authors:  Maryam Rezaii Salim; Homayoon Vahedi; Zia Salimi; Hossein Froutan; Masoud Sotoudeh
Journal:  Middle East J Dig Dis       Date:  2011-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.